抑制PARP可以通过促进STAT1酸化来增强介质干细胞/干细胞的免疫调节功能
Tingting Wang1, Yanan Li1, Jinyi Tian1
1Institutes for Translational Medicine, State Key Laboratory of Radiation Medicine and Protection, The Third Affiliated Hospital of Soochow University, Suzhou Medical College of Soochow University, Suzhou, 215123, Jiangsu, China.
Stem cell research & therapy
|October 8, 2025
概括
抑制多ADP-ribose聚合酶1 (PARP1) 增强了介酶干细胞/干细胞 (MSC) 的免疫调节功能. 这一策略通过增加免疫抑制因子表达来提高MSC在自身免疫和炎症性疾病中的治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 介酶干细胞/介酶干细胞 (MSCs) 具有强大的免疫调节特性,对自身免疫和超炎症性疾病有益.
- 炎症性细胞因子对于激活MSC免疫调节功能至关重要,但基本机制尚未完全理解.
研究的目的:
- 调查多ADP- рибо聚合酶1 (PARP1) 在调节MSC免疫调节功能的作用.
- 探索PARP抑制作为一种提高MSC治疗疗效的策略.
主要方法:
- 多样性瘤被用IFNγ和TNFα治疗,有或没有PARP1抑制 (药理或遗传).
- 分析了免疫调节分子的基因和蛋白质表达.
- 在急性肝损伤和炎症性肠病的小鼠模型中评估了MSC的治疗效果.
- 研究了STAT1酸化在PARP抑制媒介增强中的参与.
主要成果:
- 抑制PARP显著增强了MSC的免疫调节功能和免疫抑制能力.
- PARP抑制通过STAT1酸化增加了免疫抑制因子的表达.
- 增强的MSC在自身免疫和炎症性疾病的临床前模型中显示出更好的治疗效果.
结论:
- PARP1负面调节MSCs的免疫抑制作用.
- 抑制PARP是一种有前途的策略,可以增强MSCs对免疫相关疾病的治疗能力.
相关概念视频
The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Regulation of Hematopoietic Stem Cells
4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K

